[Scoring of disseminated intravascular coagulation (DIC) in intensive care medicine]

C J Wiedermann1, M Egi

  • 1Department of Internal Medicine, Central Hospital of Bolzano, Lorenz-Böhler-Street 5, 39100 Bolzano (BZ), Italy. christian.wiedermann@asbz.it

La Clinica Terapeutica
|September 9, 2008
PubMed

Insights

Newly developed scoring systems for disseminated intravascular coagulation (DIC) show a strong link between DIC and poor outcomes in critically ill patients. Early DIC detection via these scores may improve patient management and guide future treatment trials.

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Pathophysiology

Background:

  • Disseminated intravascular coagulation (DIC) is associated with significant morbidity and mortality in critically ill patients.
  • Current validation of new DIC scoring systems highlights this close association.
  • Standardized quantification of pathological coagulation activation is crucial for patient management.

Purpose of the Study:

  • To evaluate the role of novel DIC scoring systems in identifying patients at risk.
  • To emphasize the potential of early DIC detection in critical illness management.
  • To highlight the need for further research into therapeutic interventions for DIC.

Main Methods:

  • Ongoing validation of newly developed DIC scoring systems.
  • Analysis of the predictive power of DIC scores for morbidity and mortality.
  • Review of existing data on antithrombin therapy for DIC.

Main Results:

  • DIC scoring systems demonstrate a close association with increased morbidity and mortality in the critically ill.
  • Early identification of DIC through scoring may widen the therapeutic window before irreversible organ failure.
  • Randomized controlled trials on antithrombin for DIC treatment remain limited.

Conclusions:

  • Novel DIC scores can aid in early detection and risk stratification of critically ill patients.
  • Early DIC identification is vital for optimizing management strategies and potentially improving outcomes.
  • Further research, particularly randomized controlled trials, is needed to establish effective DIC treatments like antithrombin therapy.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...